Governance Celltrion, Inc.

A068270

KR7068270008

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 20/07/2026			5-day change	1st Jan Change
1,72,600.00 ^KRW	-1.82%		-1.43%	+0.13%

14/07	Celltrion Terminates, Withdraws EMA Trial Application for CT-P51 Biosimilar	MT
07/07	Celltrion Submits Amendment for Phase 3 Trial of Cancer Biosimilar to US FDA	MT

Executive Committee: Celltrion, Inc.

Manager

Positions heldSince

Jin-Seok Seo

42 year

Chief Executive Officer

26/03/2021

Sun-Sin Jeong

60 year

General Counsel

Kyung-Ha Shin

53 year

General Counsel

Byeong-Seo Choi

57 year

Sales & Marketing

Wu-Sung Ki

65 year

Chief Executive Officer

20/03/2015

Jeong-Su Seo

67 year

Human Resources Officer

Hyun-Joo Yang

55 year

Human Resources Officer

Hyeok-Jae Lee

50 year

President

13/02/2026

Ho-Seop Lee

51 year

Director of Finance/CFO

Gi-Seong Kw

57 year

Chief Tech/Sci/R&D Officer

Seon-Jae Lee

50 year

Investor Relations Contact

Composition of the Board of Directors: Celltrion, Inc.

Director

CommitteesSince

Jung-Jin Seo

68 year

Nominating Committee

Jae-Sik Lee

68 year

Compensation Committee
Nominating Committee
Audit Committee Chair

Geun-Young Kim

66 year

Audit Committee
Compensation Committee
Nominating Committee

Dae-Hyeon Yoo

67 year

Audit Committee
Compensation Committee
Nominating Committee Chair

Joong-Jae Lee

63 year

Audit Committee	28/12/2023
Compensation Committee	28/12/2023
Nominating Committee	28/12/2023

Young-Hye Ko

71 year

Audit Committee	25/03/2022
Compensation Committee	25/03/2022
Nominating Committee	25/03/2022

Won-Kyung Choi

53 year

Audit Committee	28/12/2023
Compensation Committee	28/12/2023
Nominating Committee	28/12/2023

Jong-Moon Choi

67 year

Audit Committee	28/12/2023
Compensation Committee	28/12/2023
Nominating Committee	28/12/2023

Soon-Woo Lee

75 year

Audit Committee
Nominating Committee
Compensation Committee Chair

Hyung-Ki Kim

61 year

Director/Board Member

01/04/2005

Wu-Sung Ki

65 year

Director/Board Member

24/04/2007

Jin-Seok Seo

42 year

Director/Board Member

26/03/2021

Latest Appointments: Celltrion, Inc.

07/23/07

Celltrion Group Creator Expected to Resume Leadership Role

More news

Former Officers and Directors: Celltrion, Inc.

Insider

Positions held

SinceUntil

Won-Seok Kim

Director/Board Member	-	01/04/2022
Independent Dir/Board Member	-	01/04/2022

Jong-Seok Lee

Director/Board Member	08/12/2014	-
Independent Dir/Board Member	08/12/2014	-

Byung-Hoon Jeon

Director/Board Member	27/03/2014	-
Independent Dir/Board Member	27/03/2014	-

Hong-Hee Cho

Director/Board Member	22/03/2013	-
Independent Dir/Board Member	22/03/2013	-

Zheru Zhang

Chief Tech/Sci/R&D Officer

01/03/2008

01/10/2012

Jin-Kyu Wang

Corporate Officer/Principal

02/06/2011

30/04/2012

Brian Byeoung Kim

Corporate Officer/Principal

01/06/2011

30/04/2012

Daniel P. Slone

Corporate Officer/Principal

01/06/2011

John S. Kim

Corporate Officer/Principal

02/06/2011

Hans-Peter Hasler

Director/Board Member	01/06/2011	-
Independent Dir/Board Member	01/06/2011	-

Gyun-Seok Cho

Director/Board Member	20/03/2009	-
Independent Dir/Board Member	20/03/2009	-

Gyung-Ho Lee

Director/Board Member

17/07/2008

Dong-Il Kim

Director/Board Member	17/07/2008	-
Independent Dir/Board Member	17/07/2008	-

Joseph Lee

Director/Board Member	17/07/2008	-
Independent Dir/Board Member	17/07/2008	-

James Panek

Chief Executive Officer	01/01/2002	01/01/2006
Chairman	01/01/2002	01/01/2006

Shin-Jae Jang

Corporate Officer/Principal

Gail M. Ward

Corporate Officer/Principal

Seung-Seo Hong

Chief Tech/Sci/R&D Officer

01/06/2011

Sung-Han Lee

Compliance Officer	-	-
General Counsel	-	-

Elizabeth Pollitt

Corporate Officer/Principal

Alex Kudrin

Corporate Officer/Principal

Hee-Choon Yang

Corporate Officer/Principal

01/06/2011

Jae Chung

Founder	-	-
Corporate Officer/Principal	-	-

Yong-Jik Kim

Corporate Officer/Principal

01/06/2011

Min-Young Soh

Corporate Officer/Principal

01/06/2011

Serge S. Laveault

Corporate Officer/Principal

Dong-Gyu Ji

Corporate Officer/Principal

Sang-Joon Lee

Corporate Officer/Principal

Sung-Do Park

Corporate Officer/Principal

02/06/2011

Myung-Geun Oh

Chief Operating Officer	-	-
Corporate Officer/Principal	-	-

Hong-Seok Cho

Corporate Officer/Principal

02/06/2011

Yun-Sook Jang

Corporate Officer/Principal

02/06/2011

Kwang-Ho Kim

Corporate Officer/Principal

01/06/2011

Ho-Eun Yoo

Corporate Officer/Principal

02/06/2011

Ik-Sung Ahn

Corporate Officer/Principal

02/06/2011

Jae-Hyeon Kim

Corporate Officer/Principal

02/06/2011

Geun-Kyung Lee

Corporate Officer/Principal

01/06/2011

Young-Seon Kwon

Corporate Officer/Principal

02/06/2011

Bok-Jong Hyun

Corporate Officer/Principal

02/06/2011

Je-Roo Jang

Corporate Officer/Principal

02/06/2011

Seung-Heon Nam

Corporate Officer/Principal

01/06/2011

Young-Deok Gwon

Corporate Officer/Principal

Gang-Heui Cho

Corporate Officer/Principal

In-Kyu Kim

Corporate Officer/Principal

01/06/2011

Hyoung-Ki Kim

Director/Board Member	-	-
Chief Executive Officer	-	-

Age distribution of managers

Parity Men Women

Male	22
Female	3

Of which Executive Committee

Male	9
Female	2

Of which Directors

Male	11
Female	1

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.

Employees

2,680

Sector

Biotechnology & Medical Research

More about the company